# L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma

> **NCT00854425** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 40 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** L-asparaginase

## Key facts

- **NCT ID:** NCT00854425
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00854425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00854425, "L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00854425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*